Wave Life Sciences at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Wave Life Sciences takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover oligonucleotide design and chemistry, with a focus on stereopure molecules. It discusses applying small-molecule drug design principles to improve the drug-like properties of siRNA, and making and characterizing stereopure chimeric oligonucleotides.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Wave Life Sciences Cambridge, Massachusetts | |
Develops stereopure oligonucleotide medicines, including siRNA, antisense and RNA editing candidates. | Talk Wed Nov 4 09:05–09:35 Applying Small Molecule Drug Design Principles to Improve the Drug-like Properties of siRNA Designing siRNA the way chemists design small-molecule drugs, controlling each linkage to get lasting gene silencing in mouse liver and kidney. Talk Thu Nov 5 16:30–17:00 Synthesis and Characterization of Stereopure Chimeric Oligonucleotides Making and testing oligonucleotides in which every backbone link has one fixed mirror-image form, in small batches, to link structure to activity. |
Instantly find 20 buyers from Wave Life Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction